• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠T细胞针对同基因乳腺腺癌13762A产生的抑制性淋巴因子。

Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.

作者信息

Christensen N D, Kreider J W, Horetsky R L

机构信息

Department of Pathology, College of Medicine, Pennsylvania State University, Hershey 17033.

出版信息

Cancer Res. 1988 Feb 15;48(4):943-9.

PMID:2962735
Abstract

An antiproliferative suppressor lymphokine was produced from rat T-cells specifically in response to the poorly immunogenic syngeneic mammary adenocarcinoma 13762A. The tumor-induced suppressor lymphokine (TISL) was produced late in culture (peak production on Days 4 and 5) and showed strong but selective inhibitory activity on a variety of immune responses. The immune peritoneal exudate cell response to a highly immunogenic clone from the parental tumor (clone 18A) and the concanavalin A-stimulated response of nonimmune spleen cells were inhibited strongly by TISL. In contrast, the immune spleen cell response to 13762A and the lipopolysaccharide response of nonimmume spleen cells were unaffected. Preliminary molecular weight and physicochemical analysis of TISL indicated that the molecule was large (Mr greater than 350,000); partially sensitive to 75 degrees C treatment for 15 min and to pH 2.0 treatment; only partly degraded by the enzymes trypsin, chymotrypsin, and proteinase K; and completely destroyed by boiling. Although TISL was produced specifically in response to 13762A tumor, prior immunization in vivo was not necessary for the induction of the suppressor lymphokine. These results indicate that populations of rat lymphocytes contain naturally occurring TISL secreting cells, which can be activated specifically by tumor antigens such as those expressed by 13762A.

摘要

一种抗增殖抑制性淋巴因子由大鼠T细胞产生,该T细胞是对免疫原性较差的同基因乳腺腺癌13762A产生特异性反应而形成的。肿瘤诱导的抑制性淋巴因子(TISL)在培养后期产生(第4天和第5天产量达到峰值),并对多种免疫反应表现出强烈但具有选择性的抑制活性。TISL强烈抑制免疫腹膜渗出细胞对来自亲代肿瘤的高免疫原性克隆(克隆18A)的反应以及刀豆球蛋白A刺激的非免疫脾细胞反应。相比之下,免疫脾细胞对13762A的反应以及非免疫脾细胞的脂多糖反应未受影响。对TISL的初步分子量和理化分析表明,该分子较大(分子量大于350,000);对75摄氏度处理15分钟和pH 2.0处理部分敏感;仅被胰蛋白酶、胰凝乳蛋白酶和蛋白酶K部分降解;煮沸可将其完全破坏。尽管TISL是对13762A肿瘤产生特异性反应而产生的,但体内预先免疫对于抑制性淋巴因子的诱导并非必需。这些结果表明,大鼠淋巴细胞群体中含有天然存在的分泌TISL的细胞,这些细胞可被肿瘤抗原如13762A所表达的抗原特异性激活。

相似文献

1
Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.大鼠T细胞针对同基因乳腺腺癌13762A产生的抑制性淋巴因子。
Cancer Res. 1988 Feb 15;48(4):943-9.
2
Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.对13762A大鼠乳腺腺癌及其衍生克隆的不同T细胞增殖反应。
Cell Immunol. 1986 Feb;97(2):433-45. doi: 10.1016/0008-8749(86)90412-0.
3
Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.13762A大鼠乳腺腺癌自发变异克隆的免疫原性增强。
J Natl Cancer Inst. 1985 Jul;75(1):141-9.
4
Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
Cancer Res. 1980 Oct;40(10):3477-83.
5
Helper and suppressor functions of panned populations of immune peritoneal T cells with reactivity to the rat mammary adenocarcinoma 13762A.
Cell Immunol. 1988 Mar;112(1):200-13. doi: 10.1016/0008-8749(88)90288-2.
6
Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.对同基因乳腺腺癌的免疫反应。I. 同基因和异基因大鼠中肿瘤细胞生长动力学与细胞毒性反应的比较。
J Immunol. 1975 Nov;115(5):1269-76.
7
Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.对同基因乳腺腺癌的免疫反应。III. 调节细胞毒性的记忆和抑制功能的发展。
J Immunol. 1975 Nov;115(5):1282-7.
8
Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
Cancer Res. 1981 Jun;41(6):2394-400.
9
Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.对乳腺腺癌的免疫反应。V. 荷瘤大鼠的血清含有多种阻断细胞介导细胞毒性的因子。
J Immunol. 1978 Dec;121(6):2485-9.
10
Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.T细胞亚群在破坏13762A大鼠乳腺腺癌已形成转移灶中的作用。
J Natl Cancer Inst. 1986 Jul;77(1):187-93.